Welcome to ECVERY
Tylosin Tartrate injection
Tylosin Tartrate injection
Supplier Info
[China Supplier]
Contact Person : Mr. wang Andy
Tel : 86-0311-85098631
Fax : 86-0311-85096552
Product Detail
1)Tylosin Tartrate Injection:5%,10%,20% 2)packing:glass bottle:50ml*100,100*80ml 3)TT or LC terms 4)GMP certificate

Tylosin Tartrate  injection

Composition Per ml. solution: Tylosin (as tartrate) 200 mg. 20% . Injection 50ml;100ml

Composition

Per ml. solution:

Tylosin (as tartrate)

200

mg.

Description

Tylosin, a macrolide antibiotic, is active against particularly Gram-positive bacteria, some Spirochetes (including Leptospira); Actinomyces, Mycoplasmas (PPLO), Haemophilus pertussis, Moraxella bovis and some Gram-negative cocci. After parenteral administration, therapeutically active blood-concentrations of Tylosin are reached within 2 hours.

Indications

Infections caused by micro-organisms susceptible to Tylosin, like e.g. respiratory tract infections in cattle, sheep and pigs, Dysentery Doyle in pigs, Dysentery and Arthritis caused by Mycoplasmas, Mastitis and Endometritis.

Contra-indications

Hypersensitivity to Tylosin, cross-hypersensitivity to macrolides.

Side-effects

Sometimes, local irritation at the injection site may occur.

Dosage and administration

For intramuscular or subcutaneous administration.

Cattle

:

0.5-1 ml. per 10 kg. bodyweight daily, during 3-5 days.

Calves, sheep, goats

:

1.5-2 ml. per 50 kg. bodyweight daily, during 3-5 days.

Pigs

:

0.5-0.75 ml. per 10 kg. bodyweight every 12 hours, during 3 days.

Dogs, cats

:

0.5-2 ml. per 10 kg. bodyweight daily, during 3-5 days.

Withdrawal period

Meat

:

8 days

Milk

:

4 days

Storage

Store in a dry, dark place between 8°C and 15°C.

Packing

50ml*100vials.100 ml. multidose vial (80 vials per box).

Tylosin Tartrate injection

Ads by Google

About Us | Contact Us | Help | Terms & Conditions
Hot Products: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9
Copyright Notice @ 2008-2022 ECVERY Limited and/or its subsidiaries and licensors. All rights reserved.